The dual CCR2/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmdmdx-4Cv) mice-Reference-Cited by-同舟云学术

The dual CCR2/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmdmdx-4Cv) mice

Published:2018-03-21 Issue:3 Volume:13 Page:e0194421
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Liang Feng,Giordano Christian,Shang Dong,Li Qian,Petrof Basil J.^ORCID

Funder

Canadian Institutes of Health Research

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy;JK Mah;Neuromuscul Disord,2014

2. Glucocorticoid corticosteroids for Duchenne muscular dystrophy;AY Manzur;Cochrane database Syst Rev,2008

3. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy;S Acharyya;J Clin Invest,2007

4. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice;M Wehling;J Cell Biol,2001

5. Macrophage plasticity and polarization: in vivo veritas;A Sica;J Clin Invest,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological characterization of allosteric modulators: A case for chemokine receptors;Medicinal Research Reviews;2024-04-18

2. Polymeric nanoparticles delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne Muscular Dystrophy;2024-01-17

3. CCR5 antagonist: Promising agents in HIV treatment;Current Trends in Pharmacy and Pharmaceutical Chemistry;2023-11-15

4. C-C motif chemokine ligand 2 promotes myogenesis of myoblasts via the AKT-mTOR pathway;Aging;2022-12-27

5. COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients;International Journal of Molecular Sciences;2022-12-24